From: Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Protocol Details | Screening | Baseline | Year 1 | Year 2 | Year 3 |
---|---|---|---|---|---|
Time Window | Day 0 | 0-3 m | 1y ± 3 m | 2y ± 3 m | 3y ±3m |
Informed Consent | X | ||||
Demographics | X | ||||
Clinical Information | X | X | X | X | |
Local lab value collection | X | X | X | X | X |
Blood Collection (including DNA and RNA) | X | X | X | X | |
Urine Collection (random) | X | ||||
Urine Collection (1st morning & additional void) | X | X | X | X | |
MRI | X | ||||
US | X |